Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Hawaii Looks to Allow Psychologists to Prescribe Drugs

April 29, 2016 10:09 am | by Marina Starleaf Riker, Associated Press | News | Comments

State lawmakers are poised to make Hawaii one of a handful of states that allow psychologists to prescribe medication in hopes of increasing access to mental health services.

TOPICS:

Gilead’s Profit Misses Target; HCV Drug Sales Disappoint

April 29, 2016 9:54 am | by Stephanie Guzowski, Editor | News | Comments

Gilead Sciences’s earnings missed analysts’ estimates, tumbling 17 percent in the first quarter. Lower sales of the biotech company’s blockbuster hepatitis C virus (HCV) drugs, Harvoni and Sovaldi, contributed to lower-than-expected profit.

TOPICS:

Doctors Recommend Prescribing Fewer Opioids after Surgery

April 28, 2016 9:26 am | by Washington University School of Medicine | News | Comments

Bolstering new federal guidelines that advise primary care doctors to carefully weigh the prescribing of opioid painkillers, two experts are recommending that surgeons also consider cutting back on the number of take-home opioid pills prescribed to patients after surgery.

TOPICS:
Advertisement

Tiny Microscopes Reveal Hidden Role of Nervous System Cells

April 28, 2016 9:22 am | by Salk Institute | News | Comments

A microscope about the size of a penny is giving scientists a new window into the everyday activity of cells within the spinal cord. The innovative technology revealed that astrocytes—cells in the nervous system that do not conduct electrical signals and were traditionally viewed as merely supportive—unexpectedly react to intense sensation.

TOPICS:

Who Gets Hooked on Drugs? Genetic Markers Influence Addiction

April 28, 2016 9:16 am | by University of Michigan | News | Comments

Why does one person who tries cocaine get addicted, while another might use it and then leave it alone? Why do some people who kick a drug habit manage to stay clean, while others relapse? 

TOPICS:

Study Reveals COPD Linked to Increased Bacterial Invasion

April 28, 2016 8:36 am | by Vanderbilt University Medical Center | News | Comments

The investigators were interested in the function of the body's mucus membranes like those found in the nose and the lining of the lungs. 

TOPICS:

Advocates Hold NYC Protest Over Price of Pneumonia Vaccine

April 28, 2016 8:31 am | by Rachelle Blinder, Associated Press | News | Comments

About 70 people walked silently and in single file to Pfizer's headquarters, where they placed 2,500 flowers in a crib as though laying tribute on a coffin.

TOPICS:

Molecular Switch to Better Understand Signaling

April 28, 2016 8:30 am | by American Chemical Society | News | Comments

In the alphabets of our genomes, a single typo can mean the difference between health and disease.

TOPICS:
Advertisement

FDA: Yeast Infection Drug Could Cause Miscarriage

April 27, 2016 11:57 am | by Stephanie Guzowski, Editor | News | Comments

The warning came after the release of results of a Danish study that linked oral fluconazole (Diflucan), which treats yeast infections, to miscarriage.

TOPICS:

Oasmia: Positive OS Results From Phase 3 Ovarian Cancer Study

April 27, 2016 10:23 am | News | Comments

Overall Survival data from the Phase 3 study meets endpoint and demonstrates non-inferiority favoring Paclical/Apealea; will form basis for application seeking marketing approval in the United States anticipated for the end of 2016/2017.

TOPICS:

Cholesterol Levels, Not Statins, Influence Colorectal Cancer Risk

April 27, 2016 10:02 am | by University of Pennsylvania | News | Comments

Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient's risk of colorectal cancer, suggests a new, large case-control study.

TOPICS:

Valeant CEO Will Cite 'Mistakes' in Price-Hiking Strategy

April 27, 2016 9:49 am | by Matthew Perrone, AP Health Writer | News | Comments

J. Michael Pearson will issue the unusual mea culpa on Capitol Hill for the business strategy that made Valeant an industry powerhouse but also triggered a backlash against the Canadian drugmaker.

TOPICS:

MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment

April 27, 2016 9:28 am | by University of Cincinnati | News | Comments

Cancer researchers have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.

TOPICS:

The New Focus on IL-12 in Oncology Research

April 26, 2016 3:23 pm | by Dr. Premal Thaker M.D., Washington University School of Medicine; Dr. Charles Leath III, M.D., University of Alabama School of Medicine | Articles | Comments

In recent years, researchers have made considerable headway in efforts to improve both the pharmacokinetics and safety of therapies based on rIL-12 based on the use of more advanced delivery mechanisms.

TOPICS:

South Korean Pharmaceutical Market to Experience Slow Four-Year Growth

April 26, 2016 2:00 pm | by Adam Dion, MSc, Senior Industry Analyst, GlobalData | Articles | Comments

Many novel drugs are set to lose their patents by 2020, meaning South Korea’s generics market is expected to increase significantly.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading